Adherence to treatment in patients with ankylosing spondylitis.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 23515597)

Published in Clin Rheumatol on March 21, 2013

Authors

Pablo Arturi1, Emilce Edith Schneeberger, Fernando Sommerfleck, Emilio Buschiazzo, César Ledesma, José Antonio Maldonado Cocco, Gustavo Citera

Author Affiliations

1: Section of Rheumatology, Instituto de Rehabilitación Psicofísica, Echeverría 955, Buenos Aires, Argentina 1428. pabloarturi@hotmail.com

Articles cited by this

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05

Adherence to medication. N Engl J Med (2005) 39.77

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum (1984) 20.51

Spondyloarthritis. Lancet (2011) 2.25

The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol (1997) 2.13

Validation and crosscultural adaptation of an argentine spanish version of the health assessment questionnaire disability index. J Clin Rheumatol (2004) 1.70

The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol (2003) 1.58

Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am (1998) 1.37

Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum (2005) 1.26

The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol (2002) 1.25

Ankylosing spondylitis. Clinical features. Rheum Dis Clin North Am (1998) 1.24

Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol (2009) 1.21

The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy. Br J Rheumatol (1988) 1.15

Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Couns (1999) 1.15

The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis--a randomized controlled trial. J Rheumatol (1990) 1.05

Effects of a home-based exercise program on quality of life, fatigue, and depression in patients with ankylosing spondylitis. Rheumatol Int (2008) 0.93

The long-term use of D-penicillamine for treating rheumatoid arthritis: is continuous therapy necessary? Br J Rheumatol (1993) 0.93

Compliance monitoring of NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device. Br J Rheumatol (1996) 0.91

Improvement in pain intensity, spine stiffness, and mobility during a controlled individualized physiotherapy program in ankylosing spondylitis. Rheumatol Int (2011) 0.90

Construction of exercise attitude questionnaire-18 to evaluate patients' attitudes toward exercises. Int J Rehabil Res (2004) 0.86

Are swimming or aerobic exercise better than conventional exercise in ankylosing spondylitis patients? A randomized controlled study. Eur J Phys Rehabil Med (2009) 0.85

Work status among patients with ankylosing spondylitis in Argentina. J Clin Rheumatol (2008) 0.84

Exercise programs in trials for patients with ankylosing spondylitis: do they really have the potential for effectiveness? Arthritis Care Res (Hoboken) (2011) 0.82

Health locus of control, self-help and treatment adherence in relation to ankylosing spondylitis patients. Patient Educ Couns (1993) 0.79

Educational support groups of patients with ankylosing spondylitis: a preliminary report. Patient Couns Health Educ (1981) 0.75

Articles by these authors

Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol (2014) 2.52

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study. Arthritis Rheum (2013) 1.80

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial. Ann Rheum Dis (2013) 1.45

Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment. Value Health (2013) 1.01

Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol (2011) 1.00

Work productivity in rheumatoid arthritis: relationship with clinical and radiological features. Arthritis (2012) 0.90

Rheumatoid arthritis in Latin Americans enriched for Amerindian ancestry is associated with loci in chromosomes 1, 12, and 13, and the HLA class II region. Arthritis Rheum (2013) 0.89

Audiovestibular disorders in patients with ankylosing spondylitis. J Clin Rheumatol (2005) 0.87

[Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1]. Biomedica (2004) 0.85

Work status among patients with ankylosing spondylitis in Argentina. J Clin Rheumatol (2008) 0.84

Effects of functional electrostimulation on pain, muscular strength, and functional capacity in patients with osteoarthritis of the knee. J Clin Rheumatol (2004) 0.84

Retracted Quality of life of patients with rheumatoid arthritis in Argentina: reliability, validity, and sensitivity to change of a Spanish version of the Rheumatoid Arthritis Quality of Life questionnaire. Clin Rheumatol (2012) 0.83

Prevalence and clinical significance of eosinophilia in patients with rheumatoid arthritis in Argentina. J Clin Rheumatol (2008) 0.83

The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city of Buenos Aires province. J Clin Rheumatol (2010) 0.82

General characteristics of an early arthritis cohort in Argentina. Rheumatology (Oxford) (2010) 0.81

Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis. Health Qual Life Outcomes (2014) 0.81

A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis. Clin Rheumatol (2012) 0.79

Clinical significance of anti-Ro antibodies in rheumatoid arthritis. Clin Rheumatol (2008) 0.79

Fatigue assessment and its impact in the quality of life of patients with ankylosing spondylitis. Clin Rheumatol (2014) 0.79

Mycobacterium bovis and septic glenohumeral arthritis. Clin Rheumatol (2004) 0.77

An analysis of 372 patients with anterior uveitis in a large Ibero-American cohort of spondyloarthritis: the RESPONDIA Group. Clin Exp Rheumatol (2013) 0.77

Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria. Clin Rheumatol (2014) 0.77

Factors associated with disability in patients with rheumatoid arthritis. J Clin Rheumatol (2010) 0.77

Anti-20S proteasome antibodies in psoriatic arthritis. J Rheumatol (2008) 0.77

Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria. Clin Rheumatol (2013) 0.77

Effects of cigarette smoking on early arthritis: a cross-sectional study-data from the Argentine Consortium for Early Arthritis (CONAART). Rheumatol Int (2014) 0.76

Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort. Medicine (Baltimore) (2016) 0.75

Work instability in rheumatoid arthritis patients from Argentina: prevalence and associated factors. Rheumatol Int (2014) 0.75

Clinical and immunogenetic characterization in psoriatic arthritis patients. Clin Rheumatol (2014) 0.75

Epidemiology of spondyloarthritis in Argentina. Am J Med Sci (2011) 0.75

Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population. J Clin Rheumatol (2017) 0.75